This page is part of the MII Implementation Guide Molecular Tumor Board (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Extensions

Extensions

This page lists the FHIR extensions defined by the Molecular Tumor Board module (naming convention MII_EX_<Module>_<Name>). Extensions carry information the base resources and profiles cannot express; the profiles that use them are on the Profiles page.

The complete list of extensions is generated automatically on the artifacts summary.

Therapy line (Therapielinie)

This extension concept describes the therapy line of a systemic (drug-based) (prior) therapy. The therapy line is given as an integer.

Written during migration - review before release. TODO:REVIEW — the source guide described an extension mii-ex-mtb-therapielinie, which is no longer part of this package (the concept is carried by the referenced Oncology-module profiles). Confirm and either restore the artifact or keep this note.

Approval status (Zulassungsstatus)

This extension concept describes the approval status of a systemic (drug-based) (prior) therapy. It allows a medication administration to be marked as in-label, off-label or guideline-compliant — see mii-cs-mtb-zulassungsstatus.

Written during migration - review before release. TODO:REVIEW — the source guide described an extension mii-ex-mtb-zulassungsstatus, which is no longer part of this package (the CodeSystem/ValueSet mii-cs/vs-mtb-zulassungsstatus remain). Confirm and either restore the artifact or keep this note.